Cologne\/Aachen \u2014 MedTech startup Clino\u00admic, a pioneer in digi\u00adtal inten\u00adsive care medi\u00adcine, announ\u00adces the successful comple\u00adtion of a Series B finan\u00adcing round of 23 million euros. The round was co-led by the DeepT\u00adech & Climate Fund (DTCF) and a private family office. The funds will be used to expand the company\u2019s presence in inter\u00adna\u00adtio\u00adnal markets and further deve\u00adlop its AI-powered health\u00adcare solutions. <\/p>\n
A HEUKING team led by Colo\u00adgne part\u00adner Dr. Oliver B\u00f6tt\u00adcher and Sala\u00adried Part\u00adner Mark Ross\u00adbroich provi\u00added legal advice to the med-tech start-up Clino\u00admic GmbH on this finan\u00adcing round.<\/p>\n
Foun\u00added in 2019 by inten\u00adsive care physi\u00adci\u00adans at RWTH Aachen Univer\u00adsity, Clino\u00admic\u2019s goal with Mona, an AI-supported plat\u00adform for inten\u00adsive care units, is to improve medi\u00adcal decis\u00adi\u00adons, opti\u00admize work\u00adflows and signi\u00adfi\u00adcantly increase the quality of care through struc\u00adtu\u00adred, real-time data. Mona inte\u00adgra\u00adtes medi\u00adcal hard\u00adware, soft\u00adware and data analy\u00adsis in a single system and is desi\u00adgned to trans\u00adform inten\u00adsive care so that it meets both human and tech\u00adni\u00adcal stan\u00addards for pati\u00adents and medi\u00adcal staff. <\/p>\n
Georg Grie\u00adse\u00admann<\/strong>, CEO of Clino\u00admic, comm\u00adents: \u201cWe are proud to be able to further advance our vision of better inten\u00adsive care medi\u00adcine with such strong part\u00adners. This funding will enable us to expand our inter\u00adna\u00adtio\u00adnal acti\u00advi\u00adties in a targe\u00adted manner, deepen our AI exper\u00adtise and scale data-driven solutions.\u201d<\/p>\n G\u00fcnther Bogen\u00adrie\u00adder (photo)<\/strong>,<\/em> Invest\u00adment Mana\u00adger at DTCF, adds: \u201cFrom our first discus\u00adsions, it became clear how Clino\u00admic is solving key chal\u00adlenges in health\u00adcare with the help of AI \u2014 and doing so with a tangi\u00adble, measura\u00adble impact. Georg, Arne, Lukas and their outstan\u00adding team are rede\u00adfi\u00adning inten\u00adsive care medicine. <\/em><\/p>\n Clino\u00admic GmbH, a medi\u00adcal tech\u00adno\u00adlogy start-up from Aachen, was foun\u00added in 2019 as a spin-off of RWTH Aachen Univer\u00adsity and deve\u00adlops intel\u00adli\u00adgent assis\u00adtance systems for inten\u00adsive care units. Its main product, \u201cMona\u201d, uses arti\u00adfi\u00adcial intel\u00adli\u00adgence and speech proces\u00adsing to analyze medi\u00adcal data and support nursing staff. The inter\u00addi\u00adsci\u00adpli\u00adnary team curr\u00adently consists of over 70 experts. <\/p>\n Consul\u00adtant Clino\u00admic GmbH: <\/strong>HEUKING<\/strong><\/p>\n Dr. Oliver B\u00f6tt\u00adcher, Mark Ross\u00adbroich, LL. M. (King\u2019s College London) (both lead, both venture capi\u00adtal), Dr. Ruben A. Hofmann (IP, media & tech\u00adno\u00adlogy), all Cologne; About Clino\u00admic<\/strong><\/p>\n Clino\u00admic is a medi\u00adcal tech\u00adno\u00adlogy start-up foun\u00added by inten\u00adsive care physi\u00adci\u00adans from RWTH Aachen Univer\u00adsity Hospi\u00adtal. With its central solu\u00adtion Mona, the company combi\u00adnes state-of-the-art AI tech\u00adno\u00adlogy with advan\u00adced data analy\u00adsis to opti\u00admize work\u00adflows in inten\u00adsive care units, reduce the admi\u00adnis\u00adtra\u00adtive burden and sustain\u00adably improve pati\u00adent outco\u00admes. By inte\u00adgra\u00adting hard\u00adware, soft\u00adware and data services on a single plat\u00adform, Clino\u00admic is setting new global stan\u00addards in digi\u00adtal inten\u00adsive care medi\u00adcine and driving the moder\u00adniza\u00adtion of acute care world\u00adwide. www.clinomic.ai <\/p>\n About the DeepT\u00adech & Climate Fund <\/strong><\/p>\n","protected":false},"excerpt":{"rendered":" Cologne\/Aachen \u2014 MedTech startup Clino\u00admic, a pioneer in digi\u00adtal inten\u00adsive care medi\u00adcine, announ\u00adces the successful comple\u00adtion of a Series B finan\u00adcing round of 23 million euros. The round was co-led by the DeepT\u00adech & Climate Fund (DTCF) and a private family office. The funds will be used to expand the company\u2019s presence in inter\u00adna\u00adtio\u00adnal markets [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":55965,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-55967","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"\n
\nDr. Frede\u00adrik Wiemer (anti\u00adtrust law), Hamburg;
\nMichael K\u00f6mpel, Meike Dani\u00adels, Stefan Cesar (venture capi\u00adtal), all Cologne <\/p>\n
\n<\/strong>
\n The DeepT\u00adech & Climate Fund (DTCF) finan\u00adces high-growth DeepT\u00adech and Clima\u00adte\u00adTech compa\u00adnies in Germany and Europe with up to EUR 30 million per invest\u00adment. As an anchor inves\u00adtor and part\u00adner of long-term orien\u00adted Euro\u00adpean inves\u00adtors, the DTCF offers support to compa\u00adnies with long deve\u00adlo\u00adp\u00adment cycles and high finan\u00adcing requi\u00adre\u00adments in order to imple\u00adment a sustainable growth stra\u00adtegy and actively contri\u00adbu\u00adtes to the expan\u00adsion of the tech\u00adno\u00adlogy ecosys\u00adtem. The fund acts as a bridge between inves\u00adtors, SMEs and inno\u00adva\u00adtive start-ups in the fields of climate, compu\u00adting, indus\u00adtry and life scien\u00adces. Finan\u00adced by the Future Fund and the ERP Special Fund, the DTCF plans to invest 1 billion euros in the coming years to streng\u00adthen the Euro\u00adpean tech\u00adno\u00adlogy ecosys\u00adtem. www.dtcf.de <\/p>\n